Basit öğe kaydını göster

dc.contributor.authorOzturker, Can
dc.contributor.authorTas, Faruk
dc.date.accessioned2021-03-03T13:21:00Z
dc.date.available2021-03-03T13:21:00Z
dc.identifier.citationTas F., Ozturker C., "Distichiasis in association with entropion in metastatic HER2-positive breast cancer treated by pertuzumab, trastuzumab, and docetaxel combination chemotherapy", BREAST JOURNAL, 2019
dc.identifier.issn1075-122X
dc.identifier.othervv_1032021
dc.identifier.otherav_3378d2c1-e144-46eb-ab24-2fc0b4b58edd
dc.identifier.urihttp://hdl.handle.net/20.500.12627/38864
dc.identifier.urihttps://doi.org/10.1111/tbj.13697
dc.description.abstractWe report the first case of distichiasis combined with entropion in a HER2-positive metastatic breast cancer patient treated by pertuzumab, trastuzumab, and docetaxel combination therapy. After 7 months, she had ocular complaints including pain, irritation, burning, dryness, and redness in her both eyes. Ophthalmologic examination revealed distichiasis and a mild entropion involving her lower eyelids bilaterally. She remained free of symptom and in complete response to maintenance chemotherapy.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleDistichiasis in association with entropion in metastatic HER2-positive breast cancer treated by pertuzumab, trastuzumab, and docetaxel combination chemotherapy
dc.typeMakale
dc.relation.journalBREAST JOURNAL
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.contributor.firstauthorID270015


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster